Mineralys Therapeutics (MLYS) Stock
Mineralys Therapeutics (MLYS) closed at $14.48 on Nov 17, 2026; its Tenet Score is 55 of 100 against 340 Healthcare peers.
35 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $14.48
- Nov 17, 2026
- Market cap
- $1.3B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 14.45 – 45.62
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 55/100
- Mixed · 340 Healthcare peers
Industry: Drugs
Mineralys Therapeutics Inc scores 55/100. Mixed. Strongest on financial health and value, quality is the soft spot versus 340 Healthcare peers. Insufficient inputs: Tenet 55 is built from 3 of 4 pillars, from 35% of its inputs. The pillars showing a dash had no data.
Tenet Score · vs sector
n=340Factor grades
Growth omitted — no data yet.
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Drawdown Context
- ✕ Reversal Evidence
- ✕ Not-a-Value-Trap Gate
13F flows & insider trades land here.
We are a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. Our product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| AlvotechALVO | 41 | $1.4B |
| AnaptysBio IncANAB | 53 | $1.4B |
| Novavax, Inc.NVAX | 37 | $1.3B |
| Taysha Gene Therapies IncTSHA | 58 | $1.3B |
| Ocular Therapeutix IncOCUL | 51 | $1.3B |
| Innoviva IncINVA | 73 | $1.3B |
| Absci CorpABSI | 39 | $1.3B |
| Mannkind CorpMNKD | 29 | $1.3B |
| Amphastar Pharmaceuticals IncAMPH | 67 | $1.2B |
| Omeros CorporationOMER | 31 | $1.2B |
Common questions
What sector and industry is Mineralys Therapeutics in?
Mineralys Therapeutics is in the Healthcare sector and the Drugs industry.
What is Mineralys Therapeutics' Tenet Score?
Mineralys Therapeutics' Tenet Score is 55 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




